The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.
Roundhill GLP-1 & Weight Loss ETF OZEM
Morningstar’s Analysis OZEM
Will OZEM outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 65.0
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk AS ADR | 16.32 | 7.5 Mil | Healthcare |
Eli Lilly and Co | 15.81 | 7.3 Mil | Healthcare |
Roche Holding AG | 4.75 | 2.2 Mil | Healthcare |
Chugai Pharmaceutical Co Ltd | 4.48 | 2.1 Mil | Healthcare |
Zealand Pharma AS | 4.25 | 2.0 Mil | Healthcare |
AstraZeneca PLC ADR | 4.25 | 2.0 Mil | Healthcare |
Innovent Biologics Inc | 4.19 | 1.9 Mil | Healthcare |
Viking Therapeutics Inc | 3.89 | 1.8 Mil | Healthcare |
Structure Therapeutics Inc ADR | 3.75 | 1.7 Mil | Healthcare |
Amgen Inc | 3.27 | 1.5 Mil | Healthcare |